Founded by ophthalmic innovator Sean Ianchulev, MD, MPH, Iantrek is a venture-funded medical technology company pioneering bio-interventional and micro-interventional products for ophthalmic surgery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/20/25 | $42,000,000 | Series C |
aMoon Civilization Ventures Radius Special Situations Fund Sectoral Asset Management U.S. Venture Partners  Visionary Ventures Fund | undisclosed |
